BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24558429)

  • 21. Circular RNA circ-FOXP1 induced by SOX9 promotes hepatocellular carcinoma progression via sponging miR-875-3p and miR-421.
    Wang W; Li Y; Li X; Liu B; Han S; Li X; Zhang B; Li J; Sun S
    Biomed Pharmacother; 2020 Jan; 121():109517. PubMed ID: 31698267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudogene AKR1B10P1 enhances tumorigenicity and regulates epithelial-mesenchymal transition in hepatocellular carcinoma via stabilizing SOX4.
    Hao F; Fei X; Ren X; Xi Xiao J; Chen Y; Wang J
    J Cell Mol Med; 2020 Oct; 24(20):11779-11790. PubMed ID: 32924268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma.
    Zeng XC; Liu FQ; Yan R; Yi HM; Zhang T; Wang GY; Li Y; Jiang N
    Mol Cancer; 2014 Dec; 13():261. PubMed ID: 25491321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-217 targeting DKK1 promotes cancer stem cell properties via activation of the Wnt signaling pathway in hepatocellular carcinoma.
    Jiang C; Yu M; Xie X; Huang G; Peng Y; Ren D; Lin M; Liu B; Liu M; Wang W; Kuang M
    Oncol Rep; 2017 Oct; 38(4):2351-2359. PubMed ID: 28849121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma.
    Furuta M; Kozaki K; Tanimoto K; Tanaka S; Arii S; Shimamura T; Niida A; Miyano S; Inazawa J
    PLoS One; 2013; 8(3):e60155. PubMed ID: 23544130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4).
    Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y
    Int J Clin Exp Pathol; 2015; 8(1):337-44. PubMed ID: 25755720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.
    Li Y; Chen G; Yan Y; Fan Q
    Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
    Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
    J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation.
    Cheng D; Deng J; Zhang B; He X; Meng Z; Li G; Ye H; Zheng S; Wei L; Deng X; Chen R; Zhou J
    EBioMedicine; 2018 Oct; 36():159-170. PubMed ID: 30195653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of circDYNC1H1 exhibits inhibitor effect on cell proliferation and migration in hepatocellular carcinoma through miR-140-5p.
    Wang ZY; Zhu Z; Wang HF; Qin B; Liu J; Yao XH; Li WC; Chen KS
    J Cell Physiol; 2019 Aug; 234(10):17775-17785. PubMed ID: 30864145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.
    Xiao F; Zhang W; Chen L; Chen F; Xie H; Xing C; Yu X; Ding S; Chen K; Guo H; Cheng J; Zheng S; Zhou L
    J Transl Med; 2013 Aug; 11():195. PubMed ID: 23967867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DANCR contributed to hepatocellular carcinoma malignancy via sponging miR-216a-5p and modulating KLF12.
    Wang J; Pu J; Zhang Y; Yao T; Luo Z; Li W; Xu G; Liu J; Wei W; Deng Y
    J Cell Physiol; 2019 Jun; 234(6):9408-9416. PubMed ID: 30430564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel SOCS5/miR-18/miR-25 axis promotes tumorigenesis in liver cancer.
    Sanchez-Mejias A; Kwon J; Chew XH; Siemens A; Sohn HS; Jing G; Zhang B; Yang H; Tay Y
    Int J Cancer; 2019 Jan; 144(2):311-321. PubMed ID: 30191950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-522 contributes to cell proliferation of hepatocellular carcinoma by targeting DKK1 and SFRP2.
    Zhang H; Yu C; Chen M; Li Z; Tian S; Jiang J; Sun C
    Tumour Biol; 2016 Aug; 37(8):11321-9. PubMed ID: 26960688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
    Chen S; Wang L; Yao B; Liu Q; Guo C
    Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma.
    Wang Q; Yang X; Zhou X; Wu B; Zhu D; Jia W; Chu J; Wang J; Wu J; Kong L
    Biochem Biophys Res Commun; 2020 Jun; 526(4):889-897. PubMed ID: 32279994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. circHIPK3 regulates cell proliferation and migration by sponging miR-124 and regulating AQP3 expression in hepatocellular carcinoma.
    Chen G; Shi Y; Liu M; Sun J
    Cell Death Dis; 2018 Feb; 9(2):175. PubMed ID: 29415990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-922 regulates CYLD expression and promotes the cell proliferation of human hepatocellular carcinoma.
    Liu J; Su Z; Zeng Y; Zhang H; Yang S; Liu G
    Oncol Rep; 2017 Mar; 37(3):1445-1450. PubMed ID: 28184924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.